Evidence map›Paper›PMID 30387679›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2019

The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.

Ju Youn Beak, Hong Soon Kang, Wei Huang, Page H Myers, Dawn E Bowles, Anton M Jetten, Brian C Jensen

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ju Youn BeakMcAllister Heart Institute University of North Carolina School of Medicine , Chapel Hill, North Carolina.
Hong Soon KangImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health , Research Triangle Park, North Carolina.
Wei HuangMcAllister Heart Institute University of North Carolina School of Medicine , Chapel Hill, North Carolina.
Page H MyersVeterinary Medicine Section, Comparative Medicine Branch, National Institute of Environmental Health Sciences, National Institutes of Health , Research Triangle Park, North Carolina.
Dawn E BowlesDepartment of Surgery, Duke University Medical Center , Durham, North Carolina.
Anton M JettenImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health , Research Triangle Park, North Carolina.
Brian C JensenMcAllister Heart Institute University of North Carolina School of Medicine , Chapel Hill, North Carolina.ORCID 0000-0001-6430-8344
National Institutes of Health · USUniversity of North Carolina at Chapel Hill · USDuke Medical Center · US

Funding

Nuclear receptors: action, functions, and roles in diseaseZIAES101586 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI JETTEN, ANTON M · 2009 to 2025
$13.5M
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activationR01HL140067 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian C Jensen · 2018 to 2026
$4.2M
Nuclear receptors--Action, functions, &roles in diseaseZ01ES101586 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI JETTEN, ANTON M · 2003 to 2008
$3.2M
Intramural NIH HHS Z01 ES101586NHLBI NIH HHS R01 HL140067NIEHS NIH HHS Z01 ES101586
6 · The paper itself

Abstract

The nuclear receptor retinoic acid-related orphan receptor-α (RORα) regulates numerous critical biological processes, including central nervous system development, lymphocyte differentiation, and lipid metabolism. RORα has been recently identified in the heart, but very little is known about its role in cardiac physiology. We sought to determine whether RORα regulates myocardial hypertrophy and cardiomyocyte survival in the context of angiotensin II (ANG II) stimulation. For in vivo characterization of the function of RORα in the context of pathological cardiac hypertrophy and heart failure, we used the "staggerer" (RORα

Indexed as

Loss of Function MutationAngiotensin IIAnimalsCardiomegalyCells, CulturedFemaleFibroblastsHeart FailureHumansInterleukin-6MiceMice, Inbred C57BLMiddle AgedMitochondria, HeartMyocardial ContractionMyocytes, CardiacAngiotensin IIInterleukin-6Nuclear Receptor Subfamily 1, Group F, Member 1Rora protein, mouseSTAT3 Transcription Factorangiotensin IIfibroblastsgroup F, member 1hypertrophyleft ventricularmitochondrianuclearnuclear receptor subfamily 1retinoic acid-related orphan receptor-αsignal transducer and activator of transcription 3

Identifiers

PMID30387679
PMCPMC6383360
OpenAlexW2899051651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.